Product code DBL— Immunology

AFT SYSTEM PROFICIENCY TESTING PROGRAM

Classification name
Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control
Device class
Class 2
Regulation
21 CFR 866.5660
Advisory panel
Immunology
Total cleared
24
First cleared
Most recent

Market context for product code DBL

FDA has cleared 24 devices under product code DBL between 1980 and 2018, filed by 19 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Clearances per year

last 15 years

Top applicants under product code DBL

Recent clearances under product code DBL

Data sourced from openFDA. This site is unofficial and independent of the FDA.